[
    {
        "Type of cases ": "NSP Cured",
        "I Qtr 2020": "104",
        "II Qtr 2020": "125",
        "III Qtr 2020": "102",
        "IV Qtr 2020": "120",
        "Total 2020": "451",
        "%": "88.6"
    },
    {
        "Type of cases ": "NSP Treatment completed",
        "I Qtr 2020": "1",
        "II Qtr 2020": "0",
        "III Qtr 2020": "2",
        "IV Qtr 2020": "10",
        "Total 2020": "13",
        "%": "2.6"
    },
    {
        "Type of cases ": "NSP Died",
        "I Qtr 2020": "3",
        "II Qtr 2020": "5",
        "III Qtr 2020": "8",
        "IV Qtr 2020": "8",
        "Total 2020": "24",
        "%": "4.7"
    },
    {
        "Type of cases ": "NSP Failure",
        "I Qtr 2020": "0",
        "II Qtr 2020": "0",
        "III Qtr 2020": "0",
        "IV Qtr 2020": "0",
        "Total 2020": "0",
        "%": "0.0"
    },
    {
        "Type of cases ": "NSP Lost to Follow-up",
        "I Qtr 2020": "1",
        "II Qtr 2020": "3",
        "III Qtr 2020": "2",
        "IV Qtr 2020": "0",
        "Total 2020": "6",
        "%": "1.2"
    },
    {
        "Type of cases ": "NSP Not Evaluated",
        "I Qtr 2020": "0",
        "II Qtr 2020": "0",
        "III Qtr 2020": "1",
        "IV Qtr 2020": "0",
        "Total 2020": "1",
        "%": "0.2"
    },
    {
        "Type of cases ": "NSP Treatment Regimen Changed",
        "I Qtr 2020": "2",
        "II Qtr 2020": "4",
        "III Qtr 2020": "4",
        "IV Qtr 2020": "4",
        "Total 2020": "14",
        "%": "2.8"
    },
    {
        "Type of cases ": "NSP Total",
        "I Qtr 2020": "111",
        "II Qtr 2020": "137",
        "III Qtr 2020": "119",
        "IV Qtr 2020": "142",
        "Total 2020": "509",
        "%": "0"
    },
    {
        "Type of cases ": "NSN/NEP Cured",
        "I Qtr 2020": "0",
        "II Qtr 2020": "0",
        "III Qtr 2020": "0",
        "IV Qtr 2020": "0",
        "Total 2020": "0",
        "%": "0"
    },
    {
        "Type of cases ": "NSN/NEP Treatment completed",
        "I Qtr 2020": "90",
        "II Qtr 2020": "81",
        "III Qtr 2020": "82",
        "IV Qtr 2020": "118",
        "Total 2020": "371",
        "%": "91.6"
    },
    {
        "Type of cases ": "NSN/NEP Died",
        "I Qtr 2020": "7",
        "II Qtr 2020": "4",
        "III Qtr 2020": "3",
        "IV Qtr 2020": "13",
        "Total 2020": "27",
        "%": "6.7"
    },
    {
        "Type of cases ": "NSN/NEP Failure",
        "I Qtr 2020": "0",
        "II Qtr 2020": "0",
        "III Qtr 2020": "0",
        "IV Qtr 2020": "0",
        "Total 2020": "0",
        "%": "0"
    },
    {
        "Type of cases ": "NSN/NEP Lost to Follow-up",
        "I Qtr 2020": "1",
        "II Qtr 2020": "2",
        "III Qtr 2020": "0",
        "IV Qtr 2020": "2",
        "Total 2020": "5",
        "%": "1.2"
    },
    {
        "Type of cases ": "NSN/NEP Not Evaluated",
        "I Qtr 2020": "0",
        "II Qtr 2020": "1",
        "III Qtr 2020": "0",
        "IV Qtr 2020": "0",
        "Total 2020": "1",
        "%": "0.2"
    },
    {
        "Type of cases ": "NSN/NEP Treatment Regimen Changed",
        "I Qtr 2020": "1",
        "II Qtr 2020": "0",
        "III Qtr 2020": "0",
        "IV Qtr 2020": "0",
        "Total 2020": "1",
        "%": "0.2"
    },
    {
        "Type of cases ": "NSN/NEP Total",
        "I Qtr 2020": "99",
        "II Qtr 2020": "88",
        "III Qtr 2020": "85",
        "IV Qtr 2020": "133",
        "Total 2020": "405",
        "%": "0"
    },
    {
        "Type of cases ": "RT +ve Cured",
        "I Qtr 2020": "16",
        "II Qtr 2020": "10",
        "III Qtr 2020": "12",
        "IV Qtr 2020": "16",
        "Total 2020": "54",
        "%": "79.4"
    },
    {
        "Type of cases ": "RT+ve Treatment completed",
        "I Qtr 2020": "0",
        "II Qtr 2020": "0",
        "III Qtr 2020": "0",
        "IV Qtr 2020": "3",
        "Total 2020": "3",
        "%": "4.4"
    },
    {
        "Type of cases ": "RT +Ve Died",
        "I Qtr 2020": "1",
        "II Qtr 2020": "1",
        "III Qtr 2020": "2",
        "IV Qtr 2020": "1",
        "Total 2020": "5",
        "%": "7.4"
    },
    {
        "Type of cases ": "RT +ve Failure",
        "I Qtr 2020": "0",
        "II Qtr 2020": "0",
        "III Qtr 2020": "0",
        "IV Qtr 2020": "0",
        "Total 2020": "0",
        "%": "0"
    },
    {
        "Type of cases ": "RT +ve Lost to Follow-up",
        "I Qtr 2020": "1",
        "II Qtr 2020": "1",
        "III Qtr 2020": "0",
        "IV Qtr 2020": "1",
        "Total 2020": "3",
        "%": "4.4"
    },
    {
        "Type of cases ": "RT +ve Not Evaluated",
        "I Qtr 2020": "0",
        "II Qtr 2020": "0",
        "III Qtr 2020": "0",
        "IV Qtr 2020": "0",
        "Total 2020": "0",
        "%": "0"
    },
    {
        "Type of cases ": "RT +ve Treatment Regimen Changed",
        "I Qtr 2020": "0",
        "II Qtr 2020": "3",
        "III Qtr 2020": "0",
        "IV Qtr 2020": "0",
        "Total 2020": "3",
        "%": "4.4"
    },
    {
        "Type of cases ": "RT +ve Total",
        "I Qtr 2020": "18",
        "II Qtr 2020": "15",
        "III Qtr 2020": "14",
        "IV Qtr 2020": "21",
        "Total 2020": "68",
        "%": "0"
    },
    {
        "Type of cases ": "RT Neg Cured",
        "I Qtr 2020": "0",
        "II Qtr 2020": "0",
        "III Qtr 2020": "0",
        "IV Qtr 2020": "0",
        "Total 2020": "0",
        "%": "0"
    },
    {
        "Type of cases ": "RT Neg Treatment completed",
        "I Qtr 2020": "15",
        "II Qtr 2020": "6",
        "III Qtr 2020": "17",
        "IV Qtr 2020": "30",
        "Total 2020": "68",
        "%": "94.4"
    },
    {
        "Type of cases ": "RT Neg Died",
        "I Qtr 2020": "0",
        "II Qtr 2020": "1",
        "III Qtr 2020": "2",
        "IV Qtr 2020": "1",
        "Total 2020": "4",
        "%": "5.6"
    },
    {
        "Type of cases ": "RT Neg Failure",
        "I Qtr 2020": "0",
        "II Qtr 2020": "0",
        "III Qtr 2020": "0",
        "IV Qtr 2020": "0",
        "Total 2020": "0",
        "%": "0"
    },
    {
        "Type of cases ": "RT Neg Lost to Follow-up",
        "I Qtr 2020": "0",
        "II Qtr 2020": "0",
        "III Qtr 2020": "0",
        "IV Qtr 2020": "0",
        "Total 2020": "0",
        "%": "0"
    },
    {
        "Type of cases ": "RT Neg Not Evaluated",
        "I Qtr 2020": "0",
        "II Qtr 2020": "0",
        "III Qtr 2020": "0",
        "IV Qtr 2020": "0",
        "Total 2020": "0",
        "%": "0"
    },
    {
        "Type of cases ": "RT Neg Treatment Regimen Changed",
        "I Qtr 2020": "0",
        "II Qtr 2020": "0",
        "III Qtr 2020": "0",
        "IV Qtr 2020": "0",
        "Total 2020": "0",
        "%": "0"
    },
    {
        "Type of cases ": "RT Neg Total",
        "I Qtr 2020": "15",
        "II Qtr 2020": "7",
        "III Qtr 2020": "19",
        "IV Qtr 2020": "31",
        "Total 2020": "72",
        "%": "0"
    }
]